Evaluation of Osteo-Buddy in Improving Osteoporosis Knowledge
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age50+
SponsorSingHealth Polyclinics
About this trial
This is a pilot randomised controlled trial (RCT) to evaluate the use of a Virtual Health Assistant (VHA) named Osteo-Buddy in improving the knowledge of osteoporosis in older women.
Eligibility criteria
Qualifiers
Age 50 and above
Medium or high Osteoporosis Self-Assessment Tool for Asians (OSTA) score
Not undertaken Bone Mineral Density (BMD) scan
Never been treated with anti-osteoporosis medications such as bisphosphonates (e.g. alendronate, risendronate, ibandronate, zolendronate, pamidronate) or denosumab
Disqualifiers
Known terminal illness
Visual, hearing and/or cognitive impairment or mental illness that renders them unable to provide informed consent
Trial design
Treatments tested in this trial
- Osteo-Buddy
- Usual Care
Treatment groups
80 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov